The Hindu Business Line : Orchid Chem files 7 ANDAs

CHENNAI: Orchid Chemicals & Pharmaceuticals on Wednesday announced that it had filed its seventh application with the US Food and Drug Administration to sell finished products (formulations) there.

A company release said the seven applications (ANDAs) covered three antibiotic products in the cephalosporin family. The applications for the three cephalosporin products are spread over different dosage strengths. Of the three formulations, two are injectibles, and one is in oral form.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Human trials for Ranbaxy-MMV malaria drug soon

Phoenix Yule to offer 15-km conveyer belt systems

RK Marbles to expand capacity

Orchid Chem files 7 ANDAs

Balaji Tele to make pref allotment to Star group affiliate — To offer 25.1% stake at Rs 90

Eicher group completes de-merger of auto biz

Follow ICC rules, corporates told

Posco, BHP Billiton have big plans in Orissa — Talks held with CM for 10-m tonne steel plant, other projects

Alfa Laval to increase capacity in Pune plant

Wheels India to set up new plant in Haryana — Maruti to be primary customer

Ma Foi office in Raipur

Minda Instruments forms venture with Stoneridge

Dabur Foods targets Rs 5-cr profit; pins hopes on fruit juices

EIH to take management contract route for growth

NMDC to hike iron ore output

Essilor SRF looks to acquisitions for growth